SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
XYL

Xylem Inc. (XYL)

NYSE: XYL · Real-Time Price · USD
Industrials · Specialty Industrial Machinery
108.67-0.07 (-0.06%)
 
Market cap
$25.4B
Analyst consensus
Buy
Website
xylem.com
Insider Score
––Not scored
XYL Insider Score

Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

See stocks that are scored

XYL analyst forecast

XYL analyst consensus

Moderate Buy10 ratings
Buy 7 Hold 3 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

XYL 12-month price target

$140.00+28.8% upsideaverage of 2 firms
$141.00High
$139.00Low

Best analysts covering XYL

  • RBC Capital77%success rate · 13 calls
  • Stifel69%success rate · 13 calls
  • Citigroup60%success rate · 5 calls
  • Baird57%success rate · 7 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

XYL analyst ratings

FirmPrice targetAction
—JP MorganNeutral——Reiterated2026-10-19
Stifel Nicolaus—$141.00+35.5%—2026-10-19
—MizuhoNeutral——Reiterated2026-10-15
—OppenheimerOutperform——Reiterated2026-10-14
—RBC CapitalOutperform——Reiterated2026-10-14
BarclaysOverweight$139.00+35.5%Reiterated2026-10-13
—CitigroupBuy——Reiterated2026-10-12
—UBSNeutral——Reiterated2026-10-05
—JefferiesBuy——Reiterated2026-08-24
—UBSNeutral——Reiterated2026-08-13
—UBSNeutral——Reiterated2026-07-30
—MizuhoNeutral——Reiterated2026-07-29
—BarclaysOverweight——Reiterated2026-07-29
—BairdOutperform——Reiterated2026-07-29
—RBC CapitalOutperform——Reiterated2026-07-29
—StifelBuy——Reiterated2026-07-29
—StifelBuy——Reiterated2026-07-20
—RBC CapitalOutperform——Reiterated2026-07-16
—JefferiesBuy——Upgraded2026-06-25
—OppenheimerOutperform——Reiterated2026-04-29
—BarclaysOverweight——Reiterated2026-04-29
—StifelBuy——Reiterated2026-04-29
—UBSNeutral——Reiterated2026-04-29
—CitigroupBuy——Reiterated2026-04-29
—UBSNeutral——Downgraded2026-04-21
—JP MorganOverweight——Reiterated2026-04-16
—StifelBuy——Reiterated2026-04-14
—UBSBuy——Reiterated2026-04-09
—OppenheimerOutperform——Reiterated2026-04-01
—CitigroupBuy——Reiterated2026-02-11
—BarclaysOverweight——Reiterated2026-02-11
—RBC CapitalOutperform——Reiterated2026-02-11
—StifelBuy——Reiterated2026-02-11
—BarclaysOverweight——Reiterated2026-01-07
—MizuhoNeutral——Reiterated2026-01-05
—TD CowenHold——Reiterated2025-12-05
—UBSBuy——Reiterated2025-11-06
—RBC CapitalOutperform——Reiterated2025-10-29
—CitigroupBuy——Reiterated2025-10-29
—BarclaysOverweight——Reiterated2025-10-29
—StifelBuy——Reiterated2025-10-29
—CitigroupBuy——Reiterated2025-10-09
—MizuhoNeutral——Reiterated2025-09-12
—TD CowenHold——Reiterated2025-08-26
—UBSBuy——Reiterated2025-08-05
—StifelBuy——Reiterated2025-08-01
—StifelBuy——Reiterated2025-07-21
—CitigroupBuy——Reiterated2025-07-14
—RBC CapitalOutperform——Reiterated2025-04-30
—StifelBuy——Reiterated2025-04-30
—BairdOutperform——Reiterated2025-04-30
—StifelBuy——Reiterated2025-04-16
—CitigroupBuy——Reiterated2025-04-14
—BairdOutperform——Reiterated2025-02-05
—StifelBuy——Reiterated2025-01-24
—CitigroupBuy——Reiterated2025-01-13
—Wolfe ResearchPeer Perform——Downgraded2024-12-12
—StifelBuy——Reiterated2024-12-11
—CitigroupBuy——Upgraded2024-12-09
—TD CowenHold——Reiterated2024-11-06

XYL earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-02-101.411.42$2.37B$2.40B
2026-04-281.081.12$2.11B$2.13B
2026-07-281.351.46$2.34B$2.34B
2026-10-271.450.00$2.28B$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.